Please try another search
Proper guidance is often the difference between success and failure in life. The same holds true for the investing world. The need for proper guidance is all the more required now as the Q4 earnings...
Market pundits have set their eyes on Corporate America as it is gearing up to report Q4 earnings results later this week. While the broader market is expected to face a period of consolidation, bank...
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are...
Herbalife Ltd. (NYSE:HLF) has been struggling with weak sales volumes, especially in its North American and Mexico operations for a while. Unfortunately, this trend lingered in fourth-quarter 2017,...
The expected fall in JPMorgan’s (NYSE:JPM) trading revenues will likely have an adverse impact on fourth-quarter 2017 earnings given the significant dependence of its top line on this source....
Looking for a Large Cap Growth fund? You may want to consider PRIMECAP Odyssey Stock Fund POSKX as a possible option. POSKX possesses a Zacks Mutual Fund Rank of 3 (Hold), which is based on nine...
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are...
NuStar Energy L.P. (NYSE:NS) recently announced that it has started the Binding Open Season for the second capacity expansion of its Permian Crude System, operated by its unit NuStar Permian...
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are...
Novo Nordisk (CO:NOVOb) (NYSE:NVO) announced that Health Canada has approved Ozempic (semaglutide injection) to improve glycemic control in adults with type II diabetes mellitus, when metformin is...
On the lookout for a Sector - Tech fund? Starting with Columbia Seligman Comm/Info A SLMCX should not be a possibility at this time. SLMCX possesses a Zacks Mutual Fund Rank of 4 (Sell), which is...
Boston Scientific (NYSE:BSX) stock gained 8.33% to $27.96 at Jan 9’s close of trading, following the company’s announcement of an upbeat fourth-quarter 2017 preliminary sales...
Five Below, Inc. (NASDAQ:FIVE) , whose shares gained 66% against the industry’s decline of 10.1% in 2017, has kicked off 2018 with solid holiday sales numbers. The company’s net sales for...
Novartis AG (NYSE:NVS) initiated a head-to-head trial, SURPASS, on psoriasis drug, Cosentyx. The drug will be compared to its proposed biosimilar for the treatment of ankylosing spondylitis (AS).The...
Ameriprise Financial (NYSE:AMP) remains well positioned to grow through strategic acquisitions, given its strong liquidity position. Further, the company’s efforts to modify product and...